Theleme Partners LLP
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Theleme Partners LLP reported 10 stock positions worth $1.7 billion. Its top holding was Moderna (MRNA) at 28.5% of the portfolio, followed by Schwab (charles) (SCHW, 16.1%) and Transunion (TRU, 13.6%). Compared with Q2 2024, it opened 3 new positions, sold out of 1, added to 2 and reduced 3. The biggest buy was a new position in Amazon.com (AMZN) and the biggest sale an exit from Wells Fargo (WFC).
- Most Recent 13F
- Q2 2026
- Location
- London, X0
- CIK
- 0001511881
- Portfolio Value
- $1.7B (Q3 2024)
- SEC Filing
- 0000919574-24-006657 ↗ filed Nov 14, 2024
Holdings Value
Holdings 10 stocks · $1.7B
| MRNA Moderna Inc. | 28.47% | 7,226,861 | $483.0M | No change |
| SCHW Schwab (charles) Corp. | 16.06% | 4,202,505 | $272.4M | Reduce -8.8% |
| TRU Transunion | 13.61% | 2,205,357 | $230.9M | Reduce -3.3% |
| EFX Equifax Inc. | 10.36% | 598,088 | $175.8M | Add +52.9% |
| HRI Herc Holdings Inc. filed as HERC HLDGS INC | 9.95% | 1,059,072 | $168.8M | Reduce -3.3% |
| AMZN Amazon.com Inc. | 7.25% | 660,000 | $123.0M | New |
| SKX Skechers USA Inc. Class A | 6.13% | 1,555,000 | $104.1M | No change |
| SHW The Sherwin-Williams Co. | 5.21% | 231,567 | $88.4M | New |
| HDB HDFC Bank Ltd.-ADR | 1.89% | 513,500 | $32.1M | Add +70.6% |
| SONY Sony Group Corp. - SP ADR | 1.05% | 185,000 | $17.9M | New |
Options reported separately and not counted above: MRNA calls ($53.3M).
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
Options Activity Q2 2024 → Q3 2024
| MRNA Moderna Inc. | call | Add +28.5% | 7,972 | $53.3M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $1.7B | MRNA, META, UBER, AMZN, TRU |
| Q1 2026 | 9 | $1.5B | MRNA, META, UBER, TRU, AMZN |
| Q4 2025 | 9 | $1.5B | META, MRNA, FLUT, TRU, WFC |
| Q3 2025 | 10 | $1.6B | META, WFC, MRNA, TRU, UBER |
| Q2 2025 | 10 | $1.6B | MRNA, WFC, META, TRU, FLUT |
| Q1 2025 | 12 | $1.3B | MRNA, AMZN, WFC, TRU, EFX |
| Q4 2024 | 11 | $1.5B | MRNA, BAC, WFC, AMZN, EFX |
| Q3 2024 | 10 | $1.7B | MRNA, SCHW, TRU, EFX, HRI |
| Q2 2024 | 8 | $2.0B | MRNA, SCHW, WFC, TRU, HRI |
| Q1 2024 | 7 | $1.8B | MRNA, SCHW, WFC, HRI, TRU |